Abstracts are to be submitted and presented in English.
Rules for Submission
Please read the submission rules before submitting an abstract.
Please don’t use commercial drug names, brands or trademarks. Please remove company names, websites and mail addresses from the abstract.
All submissions must be completed electronically via the online abstract submission portal. Abstracts by email will not be accepted. If you are unable to submit in this manner, please contact the Congress Managers via email email@example.com or phone +49 3643 2468-141.
Abstracts must be received by the announced deadline (30 May 2022, 11:59 pm, CET). Abstracts received after the deadline will not be considered.
The Organizing Committee reserves the right to decide whether a submission will be accepted, and the right to determine the presentation form. All accepted abstracts will be presented as posters. A limited number of abstracts will be selected for oral presentations.
The abstract submission constitutes a formal commitment by the author to present the abstract in the poster session and time slot assigned by the Scientific Committee.
The presenter will be required to register and pay for the Congress to ensure their abstract(s) are included in the final program and abstract book– deadline for presenter registration is June 06, 2022. If the presenter fails to register and pay before June 06, 2022, her/his abstract will be excluded from the scientific programme and publication.
All accepted abstracts will be published in an abstract book and online on the congress website.
Upon submission, both the submitter and the co-authors will receive an email containing all information about the abstract. The abstract text is also attached to this email. Authors are advised to proofread their abstracts because abstracts will be reproduced from the online submission. Any error in spelling, grammar or data will appear in the programme and the abstract book.
Notification of acceptance or rejection by the Scientific Committee will be emailed to the submitting author. Detailed information in which format the abstract is accepted (poster presentation or Best-of-Abstract) as well as guidelines and recommendations for each abstract type will be sent shortly after notifications to registered submitting authors.